Document ID: chunk:federal_register_of_legislation:F2025C00183:clause:1_73326
Version: federal_register_of_legislation:F2025C00183
Segment Type: clause
Provision Reference: sch 1 cl 73326
Character Range: 289366–290143

73326              Characterisation of the gene rearrangement FIP1L1‑PDGFRA in the diagnostic work‑up and management of a patient with laboratory evidence of:                                                                                                                                                                                                                                                                                                                                                                                                                          230.95
                   (a) mast cell disease; or
                   (b) idiopathic hypereosinophilic syndrome; or
                   (c) chronic eosinophilic leukaemia;
                   one or more tests